NET PROFIT (x1000 EUR)
EMPLOYEES
Biomediq A/S
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover | 0 | 0 | 0 |
Earnings before taxes | -8 | -3 | 42 |
Total assets | 16 | 30 | 146 |
Current assets | 16 | 30 | 146 |
Current liabilities | 6 | 7 | 12 |
Equity capital | 7 | 15 | 125 |
- share capital | 54 | 54 | 54 |
Employees (average) | 7 | 7 | 7 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency | 43.8% | 50.0% | 85.6% |
Turnover per employee | 0 | 0 | 0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) | |||
Current ratio | 266.7% | 428.6% | 1216.7% |
Return on equity (ROE) | -114.3% | -20.0% | 33.6% |
Change turnover | 0 | 0 | 0 |
Change turnover % | |||
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.